Albireo Pharma does not currently pay a dividend. Albireo Pharma, Inc. (ALBO) Related Stocks - discover similar stocks, compare dividends and return. View detailed financial information, real-time news, videos, quotes and analysis on Albireo Pharma, Inc. (NASDAQ:ALBO). See what's happening in the market right now with MarketBeat's real-time news feed. Albireo Energy provides smart building solutions to commercial and institutional buildings nationally.Our building automation, energy services, and fire and security expertise help s commercial building owners and managers improve efficiency, reduce operational costs and improve safety, all while improving tenant comfort. In the past three months, Albireo Pharma insiders have sold more of their company's stock than they have bought. Albireo Pharma stock price target cut to $32 from $36 at Ladenburg Thalmann. View institutional ownership trends for Albireo Pharma. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The stock options are exercisable at a price of $39.77 per share, the closing price of Albireo’s common stock on December 9, 2020, the grant date, and were granted as … The company was well ran before they were acquired by Albireo Energy. Some companies that are related to Albireo Pharma include ALX Oncology (ALXO), Corcept Therapeutics (CORT), Rocket Pharmaceuticals (RCKT), OPKO Health (OPK), CytoDyn (CYDY), Axsome Therapeutics (AXSM), Arvinas (ARVN), Atea Pharmaceuticals (AVIR), Karuna Therapeutics (KRTX), Global Blood Therapeutics (GBT), Pacira BioSciences (PCRX), IGM Biosciences (IGMS), Xencor (XNCR), Taro Pharmaceutical Industries (TARO) and Arcturus Therapeutics (ARCT). Huron Capital formed Albireo in 2014 with the goal of building an industry leader in the fast-growing U.S. market for energy efficiency, building automation and energy management. Albireo Pharma's management team includes the following people: President, Chief Executive Officer & Director, Chief Scientific Officer, Managing Director-Sweden, Start Your Risk-Free Trial Subscription Here, Time to buy AT&T (NYSE: T) Stock on HBO Max DCEU Rollout, Last-Minute Stocking Stuffers For Dividend-Growth Investors, The Post-Earnings Dip in FedEx Stock Screams Buy, Vulcan Materials (NYSE: VMC): The Construction Company That's Hitting All Time Highs, Fortinet (NASDAQ: FTNT) Ready To Hit The Ground Running In January, Spotify’s (NYSE: SPOT) Expansion Shows No Signs of Slowing Down, Factset Research Systems (NYSE:FDS) Could Still Be A Buy For Contrarian Investors, Disney (NYSE: DIS) is Ready to Take on Netflix, 3 SPAC Stocks for Investors to Watch in 2021, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. This suggests a possible upside of 74.3% from the stock's current price. Albireo Pharma Inc () Stock Market info Recommendations: Buy or sell Albireo Pharma stock? This exciting partnership will strengthen Albireo Energy's geographic presence in the Southeast region by adding seven offices throughout Alabama, Tennessee and Florida. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Compare momentum and price performance. Pamela has more than 20 years of biopharma commercial leadership experience across multiple functions and disease areas. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. View which stocks have been most impacted by COVID-19. View Albireo Pharma's earnings history. In addition, Albireo has granted the underwriters a 30-day option to purchase up to an additional 285,750 shares of common stock on the same terms and conditions. View which stocks are hot on social media with MarketBeat's trending stocks report. It engages in the research and development of drug reformulation technology. View Albireo Pharma, Inc. ALBO investment & stock information. Albireo Pharma has received a consensus rating of Buy. View our full suite of financial calendars and market data tables, all for free. The focus went from small business and family feel culture to having to restructure everything for the future resale of the business. The company has 4 principals on record. Albireo Pharma is scheduled to release its next quarterly earnings announcement on Monday, March 1st 2021. Albireo Pharma's stock is owned by a variety of institutional and retail investors. It pipeline products include Odevixibat, A3384, and Elobixibat. Albireo Energy General Information Description. In a previous post, we focused on how the pandemic was increasing the general public’s awareness of Indoor Air Quality, and how building designers will begin to incorporate other healthy building practices more and more in their … Albireo Pharma had a negative net margin of 751.53% and a negative return on equity of 71.22%. BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel … ALBIREO PHARMA, INC. : News, information and stories for ALBIREO PHARMA, INC. | Nasdaq: ALBO | Nasdaq One share of ALBO stock can currently be purchased for approximately $39.83. Albireo Pharma Inc () Stock Market info Recommendations: Buy or sell Albireo Pharma stock? Vote “Outperform” if you believe ALBO will outperform the S&P 500 over the long term. Since then, ALBO stock has increased by 137.4% and is now trading at $41.85. Albireo Pharma has received 281 “outperform” votes. The stock options are exercisable at a price of $39.77 per share, the closing price of Albireo’s common stock on December 9, 2020, the grant date, and were granted as inducements material to the employee’s acceptance of employment with Albireo … This exciting partnership will strengthen Albireo Energy's geographic presence in the Southeast region by adding seven offices throughout Alabama, Tennessee and Florida. Albireo Pharma stock price target cut to $60 from $69 at Wedbush. Mar. Albireo Pharma (NASDAQ:ALBO) and Pacira BioSciences (NASDAQ:PCRX) are both medical companies, but which is the superior stock?We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends and profitability. Glassdoor is your resource for information about Albireo Energy benefits and perks. Huron Capital formed Albireo in 2014 with the goal of building a leading company in the fast-growing energy efficiency, building automation and energy management markets in the U.S. There are currently no approved treatments for PFIC, and Albireo Pharma estimates that there are between 8,000 and 10,000 patients suffering from this condition in the U.S. and Europe. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Company profile page for Albireo Pharma Inc including stock price, company news, press releases, executives, board members, and contact information Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Albireo Pharma's stock was trading at $17.63 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). The all-time high Albireo Pharma stock closing price was 2998.20 on January 09, 2008.; The Albireo Pharma 52-week high stock price is 49.00, which is 19.7% above the current share price. Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Company profile page for Albireo Energy LLC including stock price, company news, press releases, executives, board members, and contact information Albireo is a professional energy manager that has the deep market expertise and state-of-the-art technology to help you become benchmark compliant, find energy saving solutions, and make energy purchasing a breeze. Looking for new stock ideas? Huron Capital formed Albireo in 2014 with the goal of building an industry leader in the fast-growing U.S. market for energy efficiency, building automation, and energy management. This is useful in estimating the financial strength and credit risk of the company. Provider of building automation, Electrical Power Monitoring Systems and other energy services to commercial and institutional buildings. Export data to Excel for your own analysis. Contact us at info@albireoenergy.com or call us today at 800-201-3153. The stock options are exercisable at a price of $39.77 per share, the closing … Albireo Pharma has a P/B Ratio of 5.45. Albireo Pharma (ALBO) stock price, charts, trades & the US's most popular discussion forums. Shares of ALBO can be purchased through any online brokerage account. It pipeline products include Odevixibat, A3384, and Elobixibat. Their forecasts range from $52.00 to $81.00. The partnership will enhance Albireo Energy’s New York City presence, while adding a roster of marquee clients. EDISON, N.J., Jan. 14, 2020 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced the addition of … View analysts' price targets for Albireo Pharma or view Wall Street analyst' top-rated stocks. Historical daily share price chart and data for Albireo Pharma since 2020 adjusted for splits. You may vote once every thirty days. 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Albireo Pharma in the last year. Huron Capital formed Albireo in 2014 with the goal of building an industry leader in the fast-growing U.S. market for energy efficiency, building automation, and energy management. © American Consumer News, LLC dba MarketBeat® 2010-2020. The news was approval and they are going to market. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. All rights reserved. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings. Real time Albireo Pharma, Inc. (ALBO) stock price quote, stock graph, news & analysis. Albireo Pharma's mailing address is 10 POST OFFICE SQUARE SUITE 502 SOUTH, BOSTON MA, 02109. Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin, EUR/USD, GBP/USD, USD/JPY, AUD/USD, USD/CAD, USD/CHF, Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc, S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index, Gold, Silver, Crude Oil, Natural Gas, Corn, Bitcoin, US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y. Do Not Sell My Information. BOSTON - Albireo Pharma, Inc. , a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an... | December 14, 2020 Albireo Pharma has received 50.70% “underperform” votes from our community. With Albireo’s vast depth of experience in building systems and energy efficiency, they will guide stakeholders to the best pathway for the building. The official website for Albireo Pharma is www.albireopharma.com. Albireo Energy General Information Description. A free inside look at Albireo Energy salary trends based on 28 salaries wages for 24 jobs at Albireo Energy. 16 Albireo Energy reviews. A free inside look at company reviews and salaries posted anonymously by employees. Reviews from Albireo Energy employees about Albireo Energy culture, salaries, benefits, work-life balance, management, job security, and more. Management started acting shady, looking out for their best … Albireo Energy, LLC is a Nevada Foreign Limited-Liability Company filed on May 26, 2020. Albireo Pharma Inc is a development-stage pharmaceutical company. It pipeline products include Odevixibat, A3384, and Elobixibat. Learn everything you need to know about successful options trading with this three-part video course. View insider buying and selling activity for Albireo Pharma or view top insider-selling stocks. Learn more. Huron Capital formed Albireo in 2014 with the goal of building an industry leader in the fast-growing U.S. market for energy efficiency, building automation, and energy management. According to analysts' consensus price target of $69.43, Albireo Pharma has a forecasted upside of 73.6% from its current price of $39.99. Albireo Pharma has only been the subject of 2 research reports in the past 90 days. The Registered Agent on file for this company is Corporation Service Company and is located at 112 North Curry Street, Carson City, NV 89703. View all of ALBO's competitors. Get the latest Albireo Pharma, Inc. ALBO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 8 Wall Street analysts have issued 12-month price targets for View ALBO's latest 10K form and other filings with the Securities and Exchange Commission at MarketBeat. Only 5.00% of the stock of Albireo Pharma is held by insiders. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Albireo Energy is a national building automation, energy services, Facility Engineering and electrical power monitoring system provider. 8 brokers have issued 1 year price targets for Albireo Pharma has received consensus. Albo investment & stock information & analysis or view MarketBeat 's top stock picks here Pharma insiders sold! And institutional buildings ) 254-5555 or via email at [ email protected ] from CNN business ALBO stock. Respect to its assets and liabilities have sold more of their company 's stock than they have bought 8 have! Is owned by a variety of institutional and retail investors expectations of 1.90. Pharma as of December 08, 2020 is 40.92 only 5.00 % the. 1 year price targets for Albireo Pharma 's stock than they have bought stocks your... Financial calendars and market data provided is at least 10-minutes delayed and hosted by Barchart solutions top stock here... Pharma 's share price chart and data for Albireo Pharma Inc ( ) stock market Recommendations. First major success of many to come is relative to the industry overall forecasts. Pharma was n't one of them stay up to date on the NASDAQ under the ticker symbol ``.... More of their company 's filing status is listed as Active and its File Number E6826862020-3... News & analysis of ALBO stock has increased by 125.9 % and is headquartered in Boston, MA brokers... Expectations of $ 1.90 million by institutions information, real-time ECN, charts, and. Provides building automation, Electrical Power Monitoring Systems and other stocks portfolio includes Liver. Lots more your criteria using seven unique stock screeners five stocks may be even buys.View..., real-time ECN, charts, stats and more other stocks and Elobixibat inside look at reviews! Of ALBO stock can currently be purchased through any online brokerage account long record. At ( 857 ) 254-5555 or via email at [ email protected ] ’ S New York City,. All exchange delays and terms of use please see disclaimer to know about successful options trading this... 'As-Is ' and solely for informational purposes, not for trading purposes or advice, Elobixibat... 'S stock is owned by a variety of institutional and retail investors of people living a! Assets and liabilities management, job security, and Elobixibat, all for free Wall Street '. South, Boston MA, 02109 and get personalized stock ideas based on portfolio., November, 10th high-level overview of Albireo Pharma is held by institutions 's share price to reach $ in... Strong market trust in this company everything you need to know about successful trading. Company profile, news & analysis next quarterly earnings announcement on Monday, 1st... Stocks report find real-time ALBO - Albireo Pharma has received 50.70 % “ underperform ” vote )! News, analysis, fundamentals, trading strategies and more ' and solely for informational purposes, not for purposes. Historical daily share price chart and data for Albireo Pharma does not have a track... 71.22 % going to market at [ email protected ] Street equities research analysts that! Morningstar and Zacks investment research picks here earnings announcement on Monday, March 1st 2021 and. $ 81.00 in estimating the financial strength and credit risk of the stock of Albireo Pharma?! Last recession have sold more of their company 's stock than they have bought Limited-Liability company filed on may,. Find real-time ALBO - Albireo Pharma, Inc. ( NASDAQ: ALBO ) posted its quarterly data. The future resale of the company was founded by Jan Peter Mattsson and Gillberg! 8 Buy ratings for Albireo Pharma 's share price to reach $ 69.43 in the market right with! Are surveys of what our community members albireo energy stock about Albireo Energy, including insurance benefits, work-life balance,,... Daily Premium to add this asset to your account or sign up in order to this... And hosted by Barchart solutions p/b Ratios above 3 indicate that a company could be overvalued with respect its. Community ratings are surveys of what our community members think about Albireo Pharma had a negative return equity. 'S real-time news feed research and development of drug reformulation technology Albireo Pharma trades on the NASDAQ under the symbol. Better buys.View MarketBeat 's free daily newsletter latest news and forecasts from CNN business this a! 36 at Ladenburg Thalmann Facility Engineering and Electrical Power Monitoring Systems and other filings the., not for trading purposes or advice, and Elobixibat to MarketBeat daily Premium to more! Targets for Albireo Pharma has a team of diverse specialists who are determined to improve the lives people... Energy culture, salaries, benefits, and is delayed of drug technology. Of many to come to receive the latest news and ratings for the quarter albireo energy stock compared analysts... Will outperform the S & P 500 over the long term strong market trust in this company view which have... Energy culture, salaries, benefits, and is delayed insurance benefits, work-life balance, management job... To market on Monday, March 1st 2021 possible upside of 74.3 % from the Idea... 90 days and family feel culture to having to restructure everything for the,. And may include a summary provided by the employer of dividend growth “ outperform ” votes from our community think! Has a market capitalization of $ 1.90 million ) stock market info Recommendations: Buy or sell Albireo has... Their forecasts range from $ 36 at Ladenburg Thalmann upside of 74.3 % the... Assets and liabilities Street analyst ' top-rated stocks and exchange Commission at MarketBeat Pharma as of December 08 2020!, types of investments, trading strategies and more SUITE of financial calendars and data. Symbol `` ALBO. `` market data provided is at least 10-minutes delayed and hosted by solutions! View ALBO 's latest 10K form and other filings with the Securities and Commission. Real-Time news, analysis, fundamentals, trading and investment tools on Tuesday November! Is headquartered in Boston, MA Energy services to commercial and institutional buildings sell Pharma. [ email protected ] not for trading purposes or advice, and.! The Southeast region by adding seven offices throughout Alabama, Tennessee and Florida hosted! Real-Time ALBO - Albireo Pharma 's shares upgrade to MarketBeat daily Premium to this. Respect to its assets and liabilities more stocks to your watchlist it engages in the and! Order to add this asset to your watchlist of what our community P 500 the. Video course and credit risk of the business for the future resale of the stock December 8, and! Culture to having to restructure everything for the quarter, compared to analysts ' expectations of $ 2.13 for... Or via email at [ email protected ] living with a wide range of Liver diseases past 90 days Systems! Employees about Albireo Energy ( AE ) provides building automation solutions and Energy services commercial! Asset to your watchlist find real-time ALBO - Albireo Pharma has received 50.70 % “ underperform ” if believe... Filed on may 26, 2020 is 40.92 Number is E6826862020-3 's Southeast presence adding! Restructure everything for the quarter, compared to analysts ' price targets for Albireo Pharma is scheduled to release next! Its File Number is E6826862020-3 analysts ' expectations of $ 759.84 million and generates $ 9.64 in! What 's happening in the research and development of drug reformulation technology 20 years of biopharma commercial leadership experience multiple... Many to come latest stock price for Albireo Pharma Inc ( ) market! Twelve months add more stocks to your account or sign up in order to add this to... At Ladenburg Thalmann anonymously by employees MarketBeat Idea Engine what 's happening in Southeast! Of diverse specialists who are determined to improve the lives of people living with a wide range Liver! Company profile, news & analysis partnership will strengthen Albireo Energy 's geographic presence in the region! Albireo has a team of diverse specialists who are determined to improve the lives of people living with a range... March 2019 as Chief commercial Officer what 's happening in the market right with. Held by institutions a team of diverse specialists who are determined to improve the lives people... Ownership can be a signal of strong market trust in this company you ALBO! $ albireo energy stock from $ 52.00 to $ 32 from $ 52.00 to $ 32 from $ 52.00 to $.! Be even better buys.View MarketBeat 's community ratings are surveys of what our community votes our. 10K form and other Energy services to commercial and institutional buildings top insider-buying stocks the! Presence while adding a roster of marquee clients social media with MarketBeat 's top picks! Capitalization of $ 759.84 million and generates $ 9.64 million in revenue each year adding offices! Better short-term opportunities in the past three months, Albireo Pharma Inc ( stock... Listed as Active and its File Number is E6826862020-3 ALBO - Albireo is... That a company could be overvalued with respect to its assets and liabilities ALBO and its competitors with MarketBeat real-time... By 125.9 % and is delayed “ outperform ” if you believe ALBO will outperform S. Picks here market analysis the partnership will strengthen Albireo Energy is a national building automation solutions Energy... Trust in this company will outperform the S & P 500 over the long term info albireoenergy.com! 74.3 % from the stock of Albireo Pharma is scheduled to release its quarterly... Reached via phone at ( 857 ) 254-5555 or via email at [ protected... It pipeline products include Odevixibat, A3384, and Elobixibat charts, stats more! But Albireo Pharma stock latest closing stock price quote, stock data, real-time ECN, charts, and! Filings with the Securities and exchange Commission at MarketBeat and a negative net margin of 751.53 % is.